Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Postma

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Economic evaluations of adult pneumococcal vaccination strategiesP Beutels, M J Postma
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Disability-Adjusted Life Years (Dalys) as a Composite Measure to Express the Burden of Tick-Borne Encephalitis (Tbe) in SloveniaR Šmit, M J Postma
Pharmacoeconomics|November 10, 2001
The economics of HIV vaccines: projecting the impact of HIV vaccination of infants in sub-Saharan AfricaJ M Bos, M J Postma
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost-Effectiveness of Human Papillomavirus Vaccination Programmes Parallel to Current Routine Vaccination of Young Teenage GirlsT A Westra, M J Postma
Journal of Medical Economics|February 9, 2022
The notion of Surrogacy in Health Technology Assessment: an insight in the processes of Germany, UK and FrancePanagiotis Petrou, Olga Pitsillidou, M J Postma
Expert Review of Pharmacoeconomics & Outcomes Research|July 23, 2023
Implementing a Managed Entry Agreement Framework in CyprusOlga Pitsillidou, Panagiotis Petrou, M J Postma
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Cost-effectiveness of screening for genital Chlamydia trachomatisR Welte, H Jager, M J Postma
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 16, 2006
Costs of chemotherapy in the treatment of colorectal cancerF G A Jansman, M J Postma
Pharmacoeconomics - Open|April 4, 2024
Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in CyprusOlga Pitsillidou, Panagiotis Petrou, M J Postma
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Reimbursement of Targeted Cancer Therapies Within Three Different European Health Care SystemsJ Mihajlović, C Dolk, M J Postma
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Economic evaluations of adult pneumococcal vaccination strategiesP Beutels, M J Postma
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Disability-Adjusted Life Years (Dalys) as a Composite Measure to Express the Burden of Tick-Borne Encephalitis (Tbe) in SloveniaR Šmit, M J Postma
Pharmacoeconomics|November 10, 2001
The economics of HIV vaccines: projecting the impact of HIV vaccination of infants in sub-Saharan AfricaJ M Bos, M J Postma
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost-Effectiveness of Human Papillomavirus Vaccination Programmes Parallel to Current Routine Vaccination of Young Teenage GirlsT A Westra, M J Postma
Journal of Medical Economics|February 9, 2022
The notion of Surrogacy in Health Technology Assessment: an insight in the processes of Germany, UK and FrancePanagiotis Petrou, Olga Pitsillidou, M J Postma
Expert Review of Pharmacoeconomics & Outcomes Research|July 23, 2023
Implementing a Managed Entry Agreement Framework in CyprusOlga Pitsillidou, Panagiotis Petrou, M J Postma
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Cost-effectiveness of screening for genital Chlamydia trachomatisR Welte, H Jager, M J Postma
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 16, 2006
Costs of chemotherapy in the treatment of colorectal cancerF G A Jansman, M J Postma
Pharmacoeconomics - Open|April 4, 2024
Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in CyprusOlga Pitsillidou, Panagiotis Petrou, M J Postma
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Reimbursement of Targeted Cancer Therapies Within Three Different European Health Care SystemsJ Mihajlović, C Dolk, M J Postma
Pageof 14